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Although the human adult heart was considered a terminally 
differentiated organ and incapable of renewal after injury or 
with aging for almost a century, recent studies have shown 
that the heart is capable of new cardiomyocyte formation 
and possesses varying degrees of regenerative potential 
throughout mammalian life. However, whether the cardiac 
stem cells (CSC) or the pre-existing cardiomyocytes con-
tribute to the new cardiomyocyte formation remains con-
troversial. 
This controversy started when Orlic and others reported 
in 2001 that bone marrow derived c-Kit positive (c-Kit) 
cells could regenerate infarcted myocardium, implying that 
these c-Kit cells are the CSC, while Murry and others 
demonstrated that c-Kit cells do not possess the ability to 
differentiate to cardiomyocytes three years later. This con-
troversy was temporarily settled by the narrower definition 
of CSC, i.e., only c-Kit cells that reside in the heart, instead 
of all the circulating c-Kit cells in the heart, are considered 
CSC. The controversy seems to reappear because Jesty and 
others observed in 2012 that adult c-Kit CSCs do not con-
tribute to cardiomyocytes and Senyo et al. [1] reported that 
newly formed cardiomyocytes originate from pre-existing 
cardiomyocytes, however, Ellison et al. [2] and some other 
studies demonstrated that these CSCs have the potential to 
differentiate into a variety of cardiac cell types and are the 
primary source for myocardium regeneration in both mouse 
and human hearts. Whether c-Kit CSCs contribute to the 
new cardiomyocyte formation during regeneration and/or 
with aging was not determined until a recent paper was 
published [3] in which genetic lineage tracing was em-
ployed to show that c-Kit cells minimally contributed to 
cardiomyocytes under both injury and normal conditions.   
In the study by van Berlo et al. [3], a cDNA encoding 
recombinase (Cre) fused to an internal ribosome entry se-
quence (IRES) and enhanced green fluorescent protein 
(eGFP) (Cre-IRES-eGFP) was knocked-in at the locus of 
c-kit to generate the cKit-Cre-IRES-eGFP mouse line. They 
found that the expression pattern of GFP and Cre recapitu-
lated the expression pattern of c-Kit protein in this knock-in 
mouse. When all c-Kit expressing cells were labeled per-
manently by crossing the cKit-Cre-IRES-GFP mouse to a 
reporter mouse Rosa26-CAG-loxP-STOP-loxP-eGFP, it is 
found that the c-Kit labeled cells only contributed to 
0.027% or less of total cardiomyocytes during development 
or in adult heart. If the cardiomyocytes that were fused with 
the c-Kit cells are excluded, the percentage of c-Kit derived 
cardiomyocytes is about five-times lower than the initial 
prediction. The low percentage of c-Kit derived cardiomy-
ocytes is further confirmed by the inducible c-Kit-Cre la-
beling. These c-Kit cells can differentiate to cardiomyo-
cyte-like cells in vitro, as they express cardiac markers 
GATA4, α-actinin and troponin T, which is consistent with 
the previous in vitro experiment. However, these differenti-
ated cells do not form a sarcomere. The authors concluded 
that the percentage of cardiomyocytes derived from the 
c-Kit lineage was astonishingly low and hence highly un-
likely to considerably affect cardiac function [3]. The im-
proved heart function mediated by the exogenous c-Kit cells 
[2] is unlikely attributable to c-Kit derived new cardiomyo-
cyte formation, and the mechanisms underlying the im-
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proved functions need further study [3]. This study echoes 
Porrello and Olson’s opinion that “It is possible that the 
proliferating c-kit cells, myocyte precursors, and mature 
cardiomyocytes represent distinct cell populations that do 
not share a direct lineage relationship and are not hierarchi-
cally connected. Genetic lineage-tracing techniques in mice 
may help resolve these outstanding questions, but current 
models suggest that stem cells do not contribute to myocyte 
turnover during normal aging in mice” [4].  
The conclusion that c-Kit labeled cells minimally con-
tribute to cardiomyocytes based on the genetic fate mapping 
[3] is inconsistent with work from Hsieh et al. [5]. Using 
double-transgenic MerCreMer-ZEG reporter mice by cross-
breeding transgenic Myh6-MerCreMer mice with ACTB- 
ZEG mice, Hsieh et al. found that after injury, about 15% of 
newly formed cardiomyocytes in areas bordering a myocar-
dial infarction were not derived from the pre-labeled exist-
ing cardiomyocytes (about 83% of the cardiomyocytes 
could be labeled). Their results indicate that CSCs and/or 
the non-labeled cardiomyocytes contribute to the new car-
diomyocyte formation. The discrepancy between the above 
two studies regarding the contribution of c-Kit cells to car-
diomyocyte renewal can be explained by several possibili-
ties. First, the lineage-tracing system may slightly un-
der-represent all the c-Kit cells or cardiomyocytes. The ge-
netic labeling systems in van Berlo et al.’s study represent 
about 80% of the c-Kit cells in the heart and the systems in  
Hsieh et al.’s study represent about 80% of all the cardio-
myocytes. Second, except for the c-Kit cells and pre-   
existing cardiomyocytes, there might be other sources of 
cardiac progenitor cells such as SCA-1 cells, sidepopulation 
or cardiosphere-derived cells that contribute to cardiomyo-
cyte renewal during aging or regeneration. Studies based on 
the genetic-lineage-tracing experiments should be able to 
help clarify.   
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